DODGX
Price
$264.02
Change
-$4.13 (-1.54%)
Updated
Sep 6 closing price
TRVLX
Price
$47.82
Change
-$0.52 (-1.08%)
Updated
Sep 6 closing price
Ad is loading...

DODGX vs TRVLX

Header iconDODGX vs TRVLX Comparison
Open Charts DODGX vs TRVLXBanner chart's image
Dodge & Cox Stock I
Price$264.02
Change-$4.13 (-1.54%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Value
Price$47.82
Change-$0.52 (-1.08%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DODGX vs TRVLX Comparison Chart
Loading...
VS
DODGX vs. TRVLX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DODGX is a StrongBuy and TRVLX is a StrongBuy.

FUNDAMENTALS
Fundamentals
DODGX has more cash in the bank: 116B vs. TRVLX (30.1B). DODGX pays higher dividends than TRVLX: DODGX (1.36) vs TRVLX (1.17). DODGX was incepted earlier than TRVLX: DODGX (60 years) vs TRVLX (30 years). TRVLX is a more actively managed with annual turnover of: 62.30 vs. DODGX (12.00). DODGX (2500) and TRVLX (2500) have matching initial minimum investment requirements. TRVLX annual gain was more profitable for investors over the last year : 21.54 vs. DODGX (17.60). DODGX return over 5 years is better than : 50.85 vs. TRVLX (38.50).
DODGXTRVLXDODGX / TRVLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence60 years30 years-
Gain YTD11.00715.26072%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets116B30.1B385%
Annual Yield % from dividends1.361.17117%
Returns for 1 year17.6021.5482%
Returns for 3 years13.24-2.94-451%
Returns for 5 years50.8538.50132%
Returns for 10 years54.8742.29130%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TIXT3.600.02
+0.56%
TELUS International (Cda)
UNM55.260.11
+0.20%
Unum Group
TRDA15.39-0.01
-0.06%
Entrada Therapeutics
LPTX2.90N/A
-0.17%
Leap Therapeutics
HEPA0.76-0.01
-1.42%
Hepion Pharmaceuticals